Pierre Ecclestone
Corporate Officer/Principal bei VALEO PHARMA INC.
Vermögen: - $ am 30.04.2024
Profil
Pierre Ecclestone is currently the Vice President of Business Development at Valeo Pharma, Inc. since 2023.
Prior to this, he held the same position at Aralez Pharmaceuticals Canada, Inc. from 2021 to 2023.
Before that, he worked as a Principal at Pce Pharma Consulting, Inc. from 2017 to 2021.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VALEO PHARMA INC CLASS A
-.--% | 13.09.2023 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Pierre Ecclestone
| Unternehmen | Position | Beginn |
|---|---|---|
| VALEO PHARMA INC. | Corporate Officer/Principal | 01.08.2023 |
Ehemalige bekannte Positionen von Pierre Ecclestone
| Unternehmen | Position | Ende |
|---|---|---|
| TRIBUTE PHARMACEUTICALS CANADA INC | Corporate Officer/Principal | 01.04.2023 |
| Pce Pharma Consulting, Inc. | Corporate Officer/Principal | 01.01.2021 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VALEO PHARMA INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Aralez Pharmaceuticals Canada, Inc.
 Aralez Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Aralez Pharmaceuticals Canada, Inc. operates as a pharmaceutical company which focuses on the acquisition, licensing, development, and promotion of healthcare products. It also sells Uracyst and NeoVisc internationally through a number of strategic partnerships. The company was founded by Peter Roy Riehl and Robert Paul Harris on November 14, 1994 and is headquartered in Mississauga, Canada. | Health Technology |
| Pce Pharma Consulting, Inc. |
